Farringdon Capital Ltd. Acquires Shares of 4,987 Maximus, Inc. (NYSE:MMS)

Farringdon Capital Ltd. bought a new position in shares of Maximus, Inc. (NYSE:MMS - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund bought 4,987 shares of the health services provider's stock, valued at approximately $372,000.

Other institutional investors have also recently added to or reduced their stakes in the company. UMB Bank n.a. grew its holdings in Maximus by 79.8% during the 4th quarter. UMB Bank n.a. now owns 356 shares of the health services provider's stock worth $27,000 after acquiring an additional 158 shares during the last quarter. Eastern Bank bought a new stake in Maximus during the fourth quarter valued at $29,000. V Square Quantitative Management LLC grew its holdings in Maximus by 65.9% during the 4th quarter. V Square Quantitative Management LLC now owns 453 shares of the health services provider's stock worth $34,000 after acquiring an additional 180 shares during the period. R Squared Ltd bought a new position in shares of Maximus in the 4th quarter worth about $54,000. Finally, IFP Advisors Inc lifted its stake in shares of Maximus by 62.4% in the 4th quarter. IFP Advisors Inc now owns 786 shares of the health services provider's stock valued at $59,000 after purchasing an additional 302 shares during the period. 97.21% of the stock is owned by institutional investors.

Analyst Ratings Changes

MMS has been the subject of a number of research reports. StockNews.com cut Maximus from a "buy" rating to a "hold" rating in a research note on Friday, February 14th. Raymond James raised shares of Maximus from a "market perform" rating to an "outperform" rating and set a $90.00 price objective on the stock in a research note on Thursday, January 2nd.

Maximus Stock Performance

Maximus stock traded up $0.55 during trading on Thursday, hitting $68.86. The stock had a trading volume of 70,958 shares, compared to its average volume of 654,267. Maximus, Inc. has a 1 year low of $63.77 and a 1 year high of $93.97. The company has a quick ratio of 1.72, a current ratio of 1.72 and a debt-to-equity ratio of 0.82. The stock's 50 day moving average is $67.63 and its two-hundred day moving average is $74.92. The stock has a market cap of $3.90 billion, a price-to-earnings ratio of 14.80 and a beta of 0.68.

Maximus (NYSE:MMS - Get Free Report) last posted its quarterly earnings data on Thursday, February 6th. The health services provider reported $1.61 EPS for the quarter, beating the consensus estimate of $1.39 by $0.22. Maximus had a return on equity of 21.95% and a net margin of 5.28%. As a group, analysts predict that Maximus, Inc. will post 6.15 EPS for the current year.

Maximus Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Saturday, May 31st. Shareholders of record on Thursday, May 15th will be given a dividend of $0.30 per share. The ex-dividend date of this dividend is Thursday, May 15th. This represents a $1.20 annualized dividend and a dividend yield of 1.74%. Maximus's dividend payout ratio is currently 25.81%.

Insiders Place Their Bets

In related news, Director Jan Madsen sold 2,439 shares of the stock in a transaction on Tuesday, March 18th. The stock was sold at an average price of $67.71, for a total value of $165,144.69. Following the transaction, the director now owns 18,097 shares of the company's stock, valued at $1,225,347.87. This represents a 11.88 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Ilene R. Baylinson sold 14,500 shares of the stock in a transaction on Wednesday, February 19th. The shares were sold at an average price of $68.14, for a total value of $988,030.00. Following the completion of the transaction, the insider now directly owns 2,512 shares in the company, valued at approximately $171,167.68. This represents a 85.23 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 1.60% of the company's stock.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.